Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
U.S. International Trade Commission
Matt Rizzolo, Ropes & Gray IP litigation partner, examines the various operations of the U.S. International Trade Commission (USITC) in an increasingly global world.
Matt Rizzolo, Ropes & Gray IP litigation partner, discusses the rise and impact of litigation finance, a rapidly growing third-party litigation funding model.
OECD's digital tax proposal
Kat Saunders Gregor, Ropes & Gray tax partner and co-founder of the firm’s tax controversy group, discusses the OECD’s digital tax proposal as well as actions being taken by several countries to pass digital services taxes of their own.
False Claims Act: three years after Escobar
Kirsten Mayer, Ropes & Gray litigation partner, provides an update on the False Claims Act (FCA), three years after the Supreme Court’s decision on Universal Health Services v. U.S. ex rel. Escobar.
Behavioral sciences approach to risk management
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
Section 101: confusion over patentable subject matter
Matt Rizzolo, Ropes & Gray IP litigation partner, addresses the ongoing confusion over what constitutes patentable subject matter under Section 101 of the Patent Act.